Axa XL appoints Cedric Declercq to head of technical claims and exposure management for APAC and Europe
April 9 2024 by InsuranceAsia News
-
QBE’s Gordon Wong joins MSIG Hong Kong as senior vice president
- November 15
In his new role, Wong will drive all intermediate business and oversee the growth of broker, agency and Macau channels.
-
Hannover Re Malaysia to axe about 30 roles in data and technology, special project teams
- November 15
The reinsurer told IAN that it has decided that a "very limited number of non-underwriting jobs are no longer required" and is working with the affected colleagues on all possible alternatives.
-
Edme Insurance Brokers brings on board Nochiketa Dixit as managing director
- November 14
Mumbai-based Dixit will manage retail, BFSI, IT/ITES, structured credit and affinity for the broker.
-
Edme Insurance Brokers names Sanjay Radhakrishnan as CEO
- November 13
Mumbai-based Radhakrishnan has been a founding member of Edme since its establishment following the sale of Aditya Birla Insurance Brokers to private equity firm Samara Capital Group.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
